☰

Marni Stott-Miller, Ph.D. - Publications

Affiliations: 
2012 Epidemiology University of Washington, Seattle, Seattle, WA 
Area:
Epidemiology, Cell Biology, Oncology
Tree Info Similar researchers PubMed Report error

8/24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Stott-Miller M, Schwartz SM. Reply to comment on "Type II diabetes and metabolic syndrome in relation to head and neck squamous cell carcinoma risk: A SEER-Medicare database study". Cancer Epidemiology. 38: 210. PMID 24631416 DOI: 10.1016/J.Canep.2014.02.009  0.46
2013 Stott-Miller M, Chen C, Schwartz SM. Type II diabetes and metabolic syndrome in relation to head and neck squamous cell carcinoma risk: a SEER-Medicare database study. Cancer Epidemiology. 37: 428-33. PMID 23562170 DOI: 10.1016/J.Canep.2013.03.006  0.473
2012 Stott-Miller M, Chen C, Doody DR, Carter JL, Galloway DA, Madeleine MM, Schwartz SM. A history of allergies is associated with reduced risk of oral squamous cell carcinoma. Cancer Causes & Control : Ccc. 23: 1911-9. PMID 23011537 DOI: 10.1007/S10552-012-0068-X  0.506
2012 Stott-Miller M, Chen C, Chuang SC, Lee YC, Boccia S, Brenner H, Cadoni G, Dal Maso L, La Vecchia C, Lazarus P, Levi F, Matsuo K, Morgenstern H, Müller H, Muscat J, et al. History of diabetes and risk of head and neck cancer: a pooled analysis from the international head and neck cancer epidemiology consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 294-304. PMID 22144496 DOI: 10.1158/1055-9965.Epi-11-0590  0.489
2012 Stott-Miller M, Chen C, Doody DR, Schwartz SM. Abstract 5491: A history of allergies is associated with reduced risk of oral squamous cell carcinoma Cancer Research. 72: 5491-5491. DOI: 10.1158/1538-7445.Am2012-5491  0.499
2011 Stott-Miller M, Houck JR, Lohavanichbutr P, Méndez E, Upton MP, Futran ND, Schwartz SM, Chen C. Tumor and salivary matrix metalloproteinase levels are strong diagnostic markers of oral squamous cell carcinoma. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 2628-36. PMID 21960692 DOI: 10.1158/1055-9965.Epi-11-0503  0.348
2010 Stott-Miller M, Heike CL, Kratz M, Starr JR. Increased risk of orofacial clefts associated with maternal obesity: case-control study and Monte Carlo-based bias analysis. Paediatric and Perinatal Epidemiology. 24: 502-12. PMID 20670231 DOI: 10.1111/J.1365-3016.2010.01142.X  0.316
2010 Lohavanichbutr P, Houck J, Stott-Miller M, Doody DR, Mendez E, Futran N, Upton MP, Schwartz SM, Chen C. Abstract 3052: MicroRNA as a potential diagnostic marker for oral squamous cell carcinoma Cancer Research. 70: 3052-3052. DOI: 10.1158/1538-7445.Am10-3052  0.426
Low-probability matches (unlikely to be authored by this person)
2010 Speltz ML, Collett BR, Stott-Miller M, Starr JR, Heike C, Wolfram-Aduan AM, King D, Cunningham ML. Case-control study of neurodevelopment in deformational plagiocephaly. Pediatrics. 125: e537-42. PMID 20156894 DOI: 10.1542/Peds.2009-0052  0.202
2011 Hujoel PP, Stott-Miller M. Retinal and gingival hemorrhaging and chronic hyperglycemia. Diabetes Care. 34: 181-3. PMID 20937687 DOI: 10.2337/Dc10-0901  0.193
2010 Collett BR, Stott-Miller M, Kapp-Simon KA, Cunningham ML, Speltz ML. Reading in children with orofacial clefts versus controls. Journal of Pediatric Psychology. 35: 199-208. PMID 19509183 DOI: 10.1093/Jpepsy/Jsp047  0.176
2013 Stott-Miller M, Neuhouser ML, Stanford JL. Consumption of deep-fried foods and risk of prostate cancer. The Prostate. 73: 960-9. PMID 23335051 DOI: 10.1002/pros.22643  0.168
2013 Fitzgerald LM, Kumar A, Boyle EA, Zhang Y, McIntosh LM, Kolb S, Stott-Miller M, Smith T, Karyadi DM, Ostrander EA, Hsu L, Shendure J, Stanford JL. Germline missense variants in the BTNL2 gene are associated with prostate cancer susceptibility. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1520-8. PMID 23833122 DOI: 10.1158/1055-9965.Epi-13-0345  0.149
2013 Stott-Miller M, Wright JL, Stanford JL. MSMB gene variant alters the association between prostate cancer and number of sexual partners. The Prostate. 73: 1803-9. PMID 24037734 DOI: 10.1002/pros.22719  0.136
2016 Mukherjee J, Sternhufvud C, Smith N, Bell K, Stott-Miller M, McMorrow D, Johnston S. Association Between Weight Change, Clinical Outcomes, and Health Care Costs in Patients with Type 2 Diabetes. Journal of Managed Care & Specialty Pharmacy. 22: 449-66. PMID 27123909 DOI: 10.18553/jmcp.2016.22.5.449  0.134
2014 Stott-Miller M, Zhao S, Wright JL, Kolb S, Bibikova M, Klotzle B, Ostrander EA, Fan JB, Feng Z, Stanford JL. Validation study of genes with hypermethylated promoter regions associated with prostate cancer recurrence. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1331-9. PMID 24718283 DOI: 10.1158/1055-9965.Epi-13-1000  0.132
2013 Geybels MS, Neuhouser ML, Wright JL, Stott-Miller M, Stanford JL. Coffee and tea consumption in relation to prostate cancer prognosis. Cancer Causes & Control : Ccc. 24: 1947-54. PMID 23907772 DOI: 10.1007/s10552-013-0270-5  0.116
2013 Stott-Miller M, Karyadi DM, Smith T, Kwon EM, Kolb S, Stanford JL, Ostrander EA. HOXB13 mutations in a population-based, case-control study of prostate cancer. The Prostate. 73: 634-41. PMID 23129385 DOI: 10.1002/Pros.22604  0.104
2018 Best JH, Kong AM, Lenhart GM, Sarsour K, Stott-Miller M, Hwang Y. Association Between Glucocorticoid Exposure and Healthcare Expenditures for Potential Glucocorticoid-related Adverse Events in Patients with Rheumatoid Arthritis. The Journal of Rheumatology. PMID 29335343 DOI: 10.3899/Jrheum.170418  0.094
2022 Davitte JM, Stott-Miller M, Ehm MG, Cunnington MC, Reynolds RF. Integration of Real-World Data and Genetics to Support Target Identification and Validation. Clinical Pharmacology and Therapeutics. 111: 63-76. PMID 34818443 DOI: 10.1002/cpt.2477  0.067
2020 Stott-Miller M, Müllerová H, Miller B, Tabberer M, El Baou C, Keeley T, Martinez FJ, Han M, Dransfield M, Hansel NN, Cooper CB, Woodruff P, Ortega VE, Comellas AP, Paine Iii R, et al. Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort. International Journal of Chronic Obstructive Pulmonary Disease. 15: 2467-2476. PMID 33116463 DOI: 10.2147/COPD.S267002  0.05
2018 E Brady J, Stott-Miller M, Mu G, Perera S. Treatment Patterns and Sequencing in Patients With Inflammatory Bowel Disease. Clinical Therapeutics. PMID 30126706 DOI: 10.1016/j.clinthera.2018.07.013  0.028
2018 Perera S, Yang S, Stott-Miller M, Brady J. Analysis of Healthcare Resource Utilization and Costs after the Initiation of Biologic Treatment in Patients with Ulcerative Colitis and Crohn's Disease. Journal of Health Economics and Outcomes Research. 6: 96-112. PMID 32685575 DOI: 10.36469/9791  0.025
2020 Bell CF, Priest J, Stott-Miller M, Kan H, Amelio J, Song X, Limone B, Noxon V, Costenbader KH. Real-world treatment patterns, healthcare resource utilisation and costs in patients with systemic lupus erythematosus treated with belimumab: a retrospective analysis of claims data in the USA. Lupus Science & Medicine. 7: e000357. PMID 32341790 DOI: 10.1136/lupus-2019-000357  0.016
Hide low-probability matches.